Readmission Prevention Pilot Trial in Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

July 3, 2019

Study Completion Date

October 1, 2019

Conditions
Diabetes Mellitus
Interventions
OTHER

DiaTOHC Program

"1. Patient-centered education 1a) Standardized diabetes discharge instructions and education 1b) Comprehensive discharge plan review~2. Peri-discharge coordination of care~3. A1c-based adjustment of diabetes therapy~4. Post-discharge support"

Trial Locations (1)

19140

Temple University Hospital, Philadelphia

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Temple University

OTHER

NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients | Biotech Hunter | Biotech Hunter